The liver is a crucial metabolic organ that has a key role in maintaining immune and
endocrine homeostasis. Accumulating evidence suggests that chronic liver disease might …

Cirrhotic cardiomyopathy (CCM) is defined as systolic or diastolic dysfunction in the absence
of prior heart disease or another identifiable cause in patients with cirrhosis, in whom it is an …

Nonselective beta-adrenergic blocker (NSBB) therapy for the prevention of initial and
recurrent gastrointestinal bleeding in cirrhotic patients with gastroesophageal varices has …

Abstract Approximately 30% to 70% of patients with cirrhosis have QT interval prolongation.
In patients without cirrhosis, QT prolongation is associated with an increased risk of …

BACKGROUND Corrected QT (QTc) interval is prolonged in patients with liver cirrhosis and
has been proposed to correlate with the severity of the disease. However, the effects of sex …

Background and Objectives: Cirrhotic cardiomyopathy is a chronic cardiac dysfunction
associated with liver cirrhosis, in patients without previous heart disease, irrespective of the …

Abstract Background Long QT interval (QT) and abnormal QT dispersion (QTd) are
associated with sudden death. The relationship between cardiac autonomic neuropathy …

Background In patients with liver diseases, the heart is among the most adversely affected
organs. Most of the patients with well-compensated chronic liver disease do not seek …

Background Autonomic neuropathy (AN) in cirrhotic patients has been linked to a higher risk
of cirrhosis-related complications and worse outcomes before, during or after liver …

Here, we aimed to compare the effects of two anesthetic methods (desflurane inhalation
anesthesia vs. propofol-based total intravenous anesthesia (TIVA)] on corrected QT interval …